CI Investments Inc
RPRX icon

CI Investments Inc’s Royalty Pharma RPRX Stock Holding History

CI Investments Inc’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.99M Buy
178,247
+4,584
+3% +$239K 0.03% 264
2026
Q1 		$8.33M Buy
173,663
+105,516
+155% +$4.62M 0.04% 234
2025
Q4 		$2.63M Buy
68,147
+8,266
+14% +$315K 0.01% 358
2025
Q3 		$2.11M Buy
59,881
+5,918
+11% +$214K 0.01% 363
2025
Q2 		$1.94M Buy
53,963
+46,250
+600% +$1.53M 0.01% 366
2025
Q1 		$240K Sell
7,713
-3,918
-34% -$124K ﹤0.01% 676
2024
Q4 		$297K Buy
11,631
+1,616
+16% +$42.9K ﹤0.01% 631
2024
Q3 		$283K Sell
10,015
-36
-0.4% -$997 ﹤0.01% 583
2024
Q2 		$265K Sell
10,051
-1,482
-13% -$41.1K ﹤0.01% 575
2024
Q1 		$350K Buy
11,533
+5,264
+84% +$155K ﹤0.01% 551
2023
Q4 		$176K Sell
6,269
-1,041
-14% -$28.6K ﹤0.01% 699
2023
Q3 		$198K Sell
7,310
-957
-12% -$28.4K ﹤0.01% 633
2023
Q2 		$254K Buy
8,267
+4,007
+94% +$136K ﹤0.01% 595
2023
Q1 		$153K Buy
4,260
+2,690
+171% +$99.7K ﹤0.01% 644
2022
Q4 		$62K Buy
1,570
+605
+63% +$25.3K ﹤0.01% 873
2022
Q3 		$39K Buy
965
+427
+79% +$18.2K ﹤0.01% 885
2022
Q2 		$23K Sell
538
-1,148
-68% -$47.1K ﹤0.01% 957
2022
Q1 		$66K Sell
1,686
-222
-12% -$8.72K ﹤0.01% 925
2021
Q4 		$76K Buy
1,908
+512
+37% +$19.9K ﹤0.01% 951
2021
Q3 		$50K Buy
+1,396
New +$54.3K ﹤0.01% 969

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CI Investments Inc's RPRX Position: Q2 2026 in Review

CI Investments Inc increased its Royalty Pharma (RPRX) stake by 2.6% in Q2 2026, buying an estimated $239K and bringing the position to 178,247 shares worth $9.99M. The position accounts for 0.03% of the portfolio, ranked #264.

CI Investments Inc first reported a position in RPRX in Q3 2021 and has held it in 20 quarters since. 642 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • CI Investments Inc held 178,247 shares of Royalty Pharma worth $9.99M as of Q2 2026.
  • CI Investments Inc bought 4,584 Royalty Pharma shares in Q2 2026, an estimated $239K.
  • Royalty Pharma made up 0.03% of CI Investments Inc's portfolio in Q2 2026, its #264 holding.
  • CI Investments Inc first reported a position in Royalty Pharma in Q3 2021 and has held it in 20 quarters since.
  • 642 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.